Pathological features and survival outcomes of very young patients with early breast cancer: How much is "very young"?

Breast

Volumn 22, Issue 6, 2013, Pages 1046-1051

  Cancello, Giuseppe ^a   Maisonneuve, Patrick ^a   Mazza, Manuelita ^a   Montagna, Emilia ^a   Rotmensz, Nicole ^a   Viale, Giuseppe ^a,b   Pruneri, Giancarlo ^a,b   Veronesi, Paolo ^a,b   Luini, Alberto ^a   Gentilini, Oreste ^a   Goldhirsch, Aron ^a   Colleoni, Marco ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Breast cancer; Immunohistochemistry; Prognosis; Young age

Indexed keywords

GONADORELIN; TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER GRADING; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUMOR DIFFERENTIATION; TUMOR VOLUME;

BREAST CANCER; IMMUNOHISTOCHEMISTRY; PROGNOSIS; YOUNG AGE;

ADULT; AGE FACTORS; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; YOUNG ADULT;

EID: 84887190629     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2013.08.006     Document Type: Article

References (27)

1. Bouchardy C., Fioretta G., Verkooijen H.M., Vlastos G., Schaefer P., Delaloye J.F., et al. Recent increase of breast cancer incidence among women under the age of forty. Br J Cancer 2007, 96:1743-1746.
2. Brinton L.A., Sherman M.E., Carreon J.D., Anderson W.F. Recent trends in breast cancer among younger women in the United States. JNatl Cancer Inst 2008 Nov 19, 100(22):1643-1648.
3. Walker R.A., Lees E., Webb M.B., Dearing S.J. Breast carcinomas occurring in young women (<35 years) are different. Br J Cancer 1996, 74:1796-1800.
4. Chung M., Chang H.R., Bland K.I., Wanebo H.J. Younger women with breast carcinoma have a poorer prognosis than older women. Cancer 1996, 77:97-103.
5. Swanson G.M., Lin C.S. Survival patterns among younger women with breast cancer: the effects of age, race, stage, and treatment. JNatl Cancer Inst Monogr 1994, 16:69-77.
6. Winchester D.P., Osteen R.T., Menck H.R. The national cancer data base report on breast carcinoma characteristics and outcome in relation to age. Cancer 1996, 78:1838-1843.
7. Albain K.S., Allred D.C., Clark G.M. Breast cancer outcome and predictors of outcome: are there age differentials?. JNatl Cancer Inst Monogr 1994, 16:35-42.
8. Colleoni M., Rotmensz N., Robertson C., Orlando L., Viale G., Renne G., et al. A.Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol 2002 Feb, 13(2):273-279.
9. Tang L.C., Yin W.J., Di G.H., Shen Z.Z., Shao Z.M. Unfavourable clinicopathologic features and low response rate to systemic adjuvant therapy: results with regard to poor survival in young Chinese breast cancer patients. Breast Cancer Res Treat 2010 Jul, 122(1):95-104. [Epub 2009 Sep. 17]. 10.1007/s10549-009-0537-4.
10. Kim E.K., Noh W.C., Han W., Noh D.Y. Prognostic significance of young age (<35 years) by subtype based on ER, PR, and HER2 status in breast cancer: a nationwide registry-based study. World J Surg 2011 Jun, 35(6):1244-1253. 10.1007/s00268-011-1071-1.
11. Copson E., Eccles B., Maishman T., Gerty S., Stanton L., Cutress R.I., et al. POSH study steering group prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study. J Natl Cancer Inst 2013 Jul, 105(13):978-988. [Epub 2013 May 30]. 10.1093/jnci/djt134.
12. Cancello G., Maisonneuve P., Rotmensz N., Viale G., Mastropasqua M.G., Pruneri G., et al. Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer. Ann Oncol 2010 Oct, 21(10):1974-1981.
13. Kroman N., Jensen M.B., Wohlfahrt J., Mouridsen H.T., Andersen P.K., Melbye M. Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ 2000, 320:474-478.
14. de la Rochefordiere A., Asselain B., Campana F., Scholl S.M., Fenton J., Vilcoq J.R., et al. Age as prognostic factor in premenopausal breast carcinoma. Lancet 1993, 341:1039-1043.
15. Han W., Kang S.Y. The Korean Breast Cancer Society. Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer. Breast Cancer Res Treat 2010 Jan, 119(1):193-200. [Epub 2009 Apr 7]. 10.1007/s10549-009-0388-z.
16. Viale G., Bosari S., Mazzarol G., Galimberti V., Luini A., Veronesi P., et al. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 1999, 85:2433-2438.
17. Elston C.W., Ellis I.O. Pathological prognostic factors in breast cancer: the value of histological grade in breast cancer. Histopathology 1991, 19:403-410.
18. Rosen P.P., Oberman H.A. Tumors of the mammary gland 1993, Armed Forces Institute of Pathology, Washington DC.
19. Colleoni M., Orvieto E., Nolé F., Orlando L., Minchella I., Viale G., et al. Prediction of response to primary chemotherapy for operable breast cancer. Eur J Cancer 1999, 35:574-579.
20. Harvey J.M., Clark G.M., Osborne C.K., Allred D.C. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. JClin Oncol 1999, 17:1474-1481.
21. Colleoni M., Gelber S., Goldhirsch A., Aebi S., Castiglione-Gertsch M., et al. Tamoxifen after adjuvant chemotherapy for premenopausal patients with lymph-node positive breast cancer: International Breast cancer Study Group Trial 13. JClin Oncol 2006, 20:1332-1341. International Breast Cancer Study Group.
22. Cheang M.C., Chia S.K., Voduc D., Gao D., Leung S., Snider J., et al. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. JNatl Cancer Inst 2009, 101:736-750.
23. Hugh J., Hanson J., Cheang M.C., Nielsen T.O., Perou C.M., Dumontet C., et al. Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial. JClin Oncol 2009, 27:1168-1176.
24. Collins L.C., Marotti J.D., Gelber S., Cole K., Ruddy K., Kereakoglow S., et al. Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat 2012, 131:1061-1066.
25. Anders C.K., Hsu D.S., Broadwater G., Acharya C.R., Foekens J.A., Zhang Y., et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. JClin Oncol 2008 Jul 10, 26(20):3324-3330.
26. Anders C.K., Fan C., Parker J.S., Carey L.A., Blackwell K.L., Klauber-DeMore N., et al. Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes?. JClin Oncol 2011 Jan 1, 29(1):e18-20.
27. Azim H.A., Michiels S., Bedard P.L., Singhal S.K., Criscitiello C., Ignatiadis M., et al. Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling. Clin Cancer Res 2012 Mar 1, 18(5):1341-1351.